Skip to main content
NCBI home page
Gut logoLink to Gut
. 1990 Sep;31(9):973–976. doi: 10.1136/gut.31.9.973

Reduction of gastric ulcer recurrence after suppression of Helicobacter pylori by cefixime.

M Tatsuta 1, H Ishikawa 1, H Iishi 1, S Okuda 1, Y Yokota 1
PMCID: PMC1378650  PMID: 2210464

Abstract

The effect on the recurrence of gastric ulcers after suppression of Helicobacter pylori by combined treatment with cimetidine and the antimicrobial drug cefixime was investigated. Twenty one of 43 patients with endoscopically proved gastric ulcer and H pylori infection were randomly assigned to receive cimetidine 800 mg daily for 12 weeks; the remaining 22 patients received cimetidine 800 mg daily for 12 weeks plus cefixime 100 mg daily for the last two weeks. After treatment, 88% of 17 patients on cimetidine only remained H pylori positive, whereas combined administration of cimetidine and cefixime had suppressed H pylori in 78% of 18 patients (p less than 0.05). Seventeen patients in the former group whose ulcers healed but who remained H pylori positive and 18 patients in the latter group whose ulcers healed and who were no longer infected with H pylori continued to be followed after treatment. These patients underwent endoscopy to detect ulcer recurrence if symptomatic, or at 12 and 24 weeks if asymptomatic. At 12 weeks, recurrence was observed in seven of 15 (47%) patients in whom H pylori persisted, but in only one of 14 (7%) patients in whom H pylori had been suppressed (p less than 0.05). At 24 weeks, however, recurrence rates were similar between the two groups. These findings indicate that H pylori infection may be closely related to early ulcer recurrence.

Full text

PDF
973

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brogden R. N., Pinder R. M., Sawyer P. R., Speight T. M., Avery G. S. Tri-potassium di-citrato bismuthate: a report of its pharmacological properties and therapeutic efficacy in peptic ulcer. Drugs. 1976 Dec;12(6):401–411. doi: 10.2165/00003495-197612060-00001. [DOI] [PubMed] [Google Scholar]
  2. Coghlan J. G., Gilligan D., Humphries H., McKenna D., Dooley C., Sweeney E., Keane C., O'Morain C. Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study. Lancet. 1987 Nov 14;2(8568):1109–1111. doi: 10.1016/s0140-6736(87)91545-5. [DOI] [PubMed] [Google Scholar]
  3. Dooley C. P., Cohen H. The clinical significance of Campylobacter pylori. Ann Intern Med. 1988 Jan;108(1):70–79. doi: 10.7326/0003-4819-108-1-70. [DOI] [PubMed] [Google Scholar]
  4. Goodwin C. S., Armstrong J. A., Marshall B. J. Campylobacter pyloridis, gastritis, and peptic ulceration. J Clin Pathol. 1986 Apr;39(4):353–365. doi: 10.1136/jcp.39.4.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hazell S. L., Lee A. Campylobacter pyloridis, urease, hydrogen ion back diffusion, and gastric ulcers. Lancet. 1986 Jul 5;2(8497):15–17. doi: 10.1016/s0140-6736(86)92561-4. [DOI] [PubMed] [Google Scholar]
  6. Itoh T., Yanagawa Y., Shingaki M., Takahashi M., Kai A., Ohashi M., Hamana G. Isolation of Campylobacter pyloridis from human gastric mucosa and characterization of the isolates. Microbiol Immunol. 1987;31(7):603–614. doi: 10.1111/j.1348-0421.1987.tb03121.x. [DOI] [PubMed] [Google Scholar]
  7. Jones D. M., Lessells A. M., Eldridge J. Campylobacter like organisms on the gastric mucosa: culture, histological, and serological studies. J Clin Pathol. 1984 Sep;37(9):1002–1006. doi: 10.1136/jcp.37.9.1002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sontag S., Graham D. Y., Belsito A., Weiss J., Farley A., Grunt R., Cohen N., Kinnear D., Davis W., Archambault A. Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med. 1984 Sep 13;311(11):689–693. doi: 10.1056/NEJM198409133111101. [DOI] [PubMed] [Google Scholar]
  9. Staszewski J. Smoking and cancer of the alimentary tract in Poland. Br J Cancer. 1969 Jun;23(2):247–253. doi: 10.1038/bjc.1969.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Steer H. W. The gastro-duodenal epithelium in peptic ulceration. J Pathol. 1985 Aug;146(4):355–362. doi: 10.1002/path.1711460409. [DOI] [PubMed] [Google Scholar]
  11. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983 Jun 4;1(8336):1273–1275. [PubMed] [Google Scholar]
  12. Zhao H. Y., Li G. Z., Guo J. D., Yan Z., Sun S. W., Li L. S., Duan Y. M., Yue F. Z. Furazolidone in peptic ulcer. Lancet. 1985 Aug 3;2(8449):276–277. [PubMed] [Google Scholar]
  13. Zheng Z. T., Wang Z. Y., Chu Y. X., Li Y. N., Li Q. F., Lin S. R., Xu Z. M. Double-blind short-term trial of furazolidone in peptic ulcer. Lancet. 1985 May 4;1(8436):1048–1049. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES